tiprankstipranks
Advertisement

TipRanks Clinical-Trials-Auto-Generated Newsdesk

TipRanks Reporter

TipRanks’s Recent Articles

Immuneering’s Phase 3 Pancreatic Cancer Trial Puts Atebimetinib in the Spotlight for IMRX Investors
Immuneering’s Phase 3 Pancreatic Cancer Trial Puts Atebimetinib in the Spotlight for IMRX Investors
Immuneering Corp. Class A ($IMRX) announced an update on their ongoing clinical study. The Phase 3 MAPKeeper 301...
2h ago
IMRX
Takeda Advances TAK-279 Into Phase 2a Crohn’s Study, Signaling Long-Term GI Growth Ambitions
Takeda Advances TAK-279 Into Phase 2a Crohn’s Study, Signaling Long-Term GI Growth Ambitions
Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is launching a Phase...
2h ago
TAK
Alkermes Advances Brilliance NT2 Phase 3 Trial, Raising Interest in Narcolepsy Market
Alkermes Advances Brilliance NT2 Phase 3 Trial, Raising Interest in Narcolepsy Market
Alkermes plc ($ALKS) announced an update on their ongoing clinical study. The Brilliance NT2 Study 303 is a...
2h ago
ALKS
Takeda Advances Pediatric ENTYVIO Study, Supporting Long-Term Growth Potential
Takeda Advances Pediatric ENTYVIO Study, Supporting Long-Term Growth Potential
Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is running a Phase...
2h ago
TAK
Pfizer’s Next Lyme Shot: What a Fifth-Dose VLA15 Trial Signals for PFE Investors
Pfizer’s Next Lyme Shot: What a Fifth-Dose VLA15 Trial Signals for PFE Investors
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. The study, formally titled “A Phase 3,...
2h ago
PFE
Rapport Therapeutics Advances RAP-219 Into Phase 3, Setting Up New Catalyst in Focal Seizure Market
Rapport Therapeutics Advances RAP-219 Into Phase 3, Setting Up New Catalyst in Focal Seizure Market
Rapport Therapeutics, Inc. ($RAPP) announced an update on their ongoing clinical study. Rapport Therapeutics Inc. (RAPP) has announced...
2h ago
RAPP
Genmab Advances Rina S Into Phase 2 GI Cancer Trial, Raising Long Term Pipeline Hopes
Genmab Advances Rina S Into Phase 2 GI Cancer Trial, Raising Long Term Pipeline Hopes
Genmab (Otc) ($GMAB) announced an update on their ongoing clinical study. Genmab (OTC: GMAB) has launched a Phase...
2h ago
GMAB
Pfizer Ends Early-Stage Lymphoma Combo Trial, Trimming a Small Piece of Its Oncology Upside
Pfizer Ends Early-Stage Lymphoma Combo Trial, Trimming a Small Piece of Its Oncology Upside
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has terminated a Phase...
2h ago
PFE
PANDA Trial Completion Puts iRhythm’s Pediatric Growth Story in Focus
PANDA Trial Completion Puts iRhythm’s Pediatric Growth Story in Focus
Irhythm Technologies ($IRTC) announced an update on their ongoing clinical study. The Pediatric Adhesion and New Dermal Approach...
2h ago
IRTC
AbbVie Completes Early Safety Study for ABBV-142, Nudging Pipeline Hopes Higher
AbbVie Completes Early Safety Study for ABBV-142, Nudging Pipeline Hopes Higher
Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) has completed a Phase 1a study...
2h ago
ABBV
AB Science’s Masitinib MS Trial Update: What Suspended Phase 3 Activity Means for Investors
AB Science’s Masitinib MS Trial Update: What Suspended Phase 3 Activity Means for Investors
Ab Science ($ABSCF) announced an update on their ongoing clinical study. AB Science (ABSCF) is running a late-stage...
2h ago
ABSCF
Lilly and Regeneron Advance Obesity Combo Bet as Key Tirzepatide Trial Reaches Completion
Lilly and Regeneron Advance Obesity Combo Bet as Key Tirzepatide Trial Reaches Completion
Eli Lilly And Company ($LLY), Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. The Phase...
2h ago
LLY
REGN
AstraZeneca Advances Early Liver-Function Trial That Could Shape Dosing for Future AZN Drugs
AstraZeneca Advances Early Liver-Function Trial That Could Shape Dosing for Future AZN Drugs
AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca’s new liver function trial could shape...
2d ago
AZN
Novo Nordisk Completes Key CagriSema Obesity Study, Raising the Stakes in the Weight-Loss Drug Race
Novo Nordisk Completes Key CagriSema Obesity Study, Raising the Stakes in the Weight-Loss Drug Race
Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Novo Nordisk (NVO) has updated a key...
2d ago
NVO
Prelude Therapeutics Advances First‑in‑Human PRT12396 Trial in High‑Risk Blood Cancers
Prelude Therapeutics Advances First‑in‑Human PRT12396 Trial in High‑Risk Blood Cancers
Prelude Therapeutics, Inc. ($PRLD) announced an update on their ongoing clinical study. Prelude Therapeutics, Inc. (PRLD) has begun...
5d ago
PRLD
Takeda’s SPOTLITE Study Wraps Up, Sharpening the View on Complex Fistula Care
Takeda’s SPOTLITE Study Wraps Up, Sharpening the View on Complex Fistula Care
Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. The SPOTLITE study, officially titled “Prospective...
5d ago
TAK
Arcus Advances Quemliclustat With Completed Phase 1 Metabolism Study
Arcus Advances Quemliclustat With Completed Phase 1 Metabolism Study
Arcus Biosciences ($RCUS) announced an update on their ongoing clinical study. Arcus Biosciences, Inc. is running a Phase...
5d ago
RCUS
Oculis Nears Key Milestone as Phase 3 OCS-01 Eye Drop Trial in Diabetic Macular Edema Completes
Oculis Nears Key Milestone as Phase 3 OCS-01 Eye Drop Trial in Diabetic Macular Edema Completes
Oculis Holding Ag ($OCS) announced an update on their ongoing clinical study. The Phase 3 study “A Phase...
5d ago
OCS
BD’s PosiFlush SafeScrub Study Completion: What Investors Should Watch Next
BD’s PosiFlush SafeScrub Study Completion: What Investors Should Watch Next
Becton, Dickinson and Co ($BDX) announced an update on their ongoing clinical study. The clinical study “An Investigational...
5d ago
BDX
AstraZeneca’s Calquence Gets Real World Safety Check in CLL Patients on Blood Thinners
AstraZeneca’s Calquence Gets Real World Safety Check in CLL Patients on Blood Thinners
AstraZeneca ($~AZN) announced an update on their ongoing clinical study. The CICERO study, officially titled “A Non-interventional, Prospective,...
5d ago
AZN
Madrigal Expands Resmetirom Reach With New Post-Transplant MASH Trial
Madrigal Expands Resmetirom Reach With New Post-Transplant MASH Trial
Madrigal ($MDGL) announced an update on their ongoing clinical study. The Phase 2 study titled “Phase 2, Randomized,...
7d ago
MDGL
Barinthus’ VTP-300 Hepatitis B Study Reaches Completion: What Investors Should Watch Next
Barinthus’ VTP-300 Hepatitis B Study Reaches Completion: What Investors Should Watch Next
Barinthus Biotherapeutics Plc ($BRNS) announced an update on their ongoing clinical study. The study “Efficacy of VTP-300 in...
7d ago
BRNS
AN2 Therapeutics Completes First-in-Human Trial, Setting Up the Next Catalyst for ANTX
AN2 Therapeutics Completes First-in-Human Trial, Setting Up the Next Catalyst for ANTX
AN2 Therapeutics, Inc. ($ANTX) announced an update on their ongoing clinical study. The Phase 1 trial “A Phase...
7d ago
ANTX
Amylyx’s ORION Trial in Progressive Supranuclear Palsy Reaches Completion: What Investors Should Watch
Amylyx’s ORION Trial in Progressive Supranuclear Palsy Reaches Completion: What Investors Should Watch
Amylyx Pharmaceuticals, Inc. ($AMLX) announced an update on their ongoing clinical study. The ORION study, officially titled “A...
7d ago
AMLX
ImmunityBio Targets Tough Pancreatic Cancer With New Phase 1 Combo Trial
ImmunityBio Targets Tough Pancreatic Cancer With New Phase 1 Combo Trial
Immunitybio Inc ($IBRX) announced an update on their ongoing clinical study. The study “Open-Label, Phase 1 Clinical Trial...
8d ago
IBRX
Pfizer’s Ritlecitinib Trial Targets Painful Skin Disease, Adding Quiet Upside to PFE’s Pipeline
Pfizer’s Ritlecitinib Trial Targets Painful Skin Disease, Adding Quiet Upside to PFE’s Pipeline
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is running a Phase...
8d ago
PFE
Novo Nordisk Expands Obesity Franchise Into Knee Pain With New AMAZE 5 Trial
Novo Nordisk Expands Obesity Franchise Into Knee Pain With New AMAZE 5 Trial
Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Novo Nordisk Targets Weight and Joint Pain...
8d ago
NVO
Eisai’s E6742 Lupus Trial Advances: What ESALF Investors Need to Know
Eisai’s E6742 Lupus Trial Advances: What ESALF Investors Need to Know
Eisai Co ($ESALF) announced an update on their ongoing clinical study. Eisai Co. (ESALF) is running a Phase...
9d ago
ESALF
Haleon’s New Dentin Sensitivity Study Signals Long‑Term Focus on Real‑World Oral Health
Haleon’s New Dentin Sensitivity Study Signals Long‑Term Focus on Real‑World Oral Health
Haleon PLC Sponsored ADR ($HLN) announced an update on their ongoing clinical study. Haleon PLC Sponsored ADR (HLN)...
9d ago
HLN
Bayer Refreshes Key Larotrectinib Cancer Study, Reinforcing Its Niche Oncology Edge
Bayer Refreshes Key Larotrectinib Cancer Study, Reinforcing Its Niche Oncology Edge
Bayer AG ($BAYRY) announced an update on their ongoing clinical study. The phase 2 study “A Study to...
9d ago
BAYRY
Sanofi’s Lunsekimig Trial Update: New Momentum in Chronic Sinus Disease
Sanofi’s Lunsekimig Trial Update: New Momentum in Chronic Sinus Disease
Sanofi ($SNYNF) announced an update on their ongoing clinical study. The Sanofi study, officially titled “A Randomized Phase...
9d ago
SNYNF
Sanofi Wraps Key Depakine Safety Study in Saudi Arabia: What Investors Should Watch
Sanofi Wraps Key Depakine Safety Study in Saudi Arabia: What Investors Should Watch
Sanofi ($SNYNF) announced an update on their ongoing clinical study. Sanofi Tracks Safety Measures for Depakine in Key...
9d ago
SNYNF
Oculis Advances Targeted Dry Eye Drug Licaminlimab Into Late-Stage Testing
Oculis Advances Targeted Dry Eye Drug Licaminlimab Into Late-Stage Testing
Oculis Holding Ag ($OCS) announced an update on their ongoing clinical study. The new Oculis study, titled “A...
12d ago
OCS
Evommune’s EVO756 Phase 2b Trial: An Emerging Catalyst in Atopic Dermatitis
Evommune’s EVO756 Phase 2b Trial: An Emerging Catalyst in Atopic Dermatitis
Evommune, Inc. ($EVMN) announced an update on their ongoing clinical study. The Phase 2b study of EVO756 in...
12d ago
EVMN
ResMed Steps Up PAP Innovation With New Amalfi vs. CLA11 Sleep Apnea Study
ResMed Steps Up PAP Innovation With New Amalfi vs. CLA11 Sleep Apnea Study
Resmed Inc ($RMD) announced an update on their ongoing clinical study. ResMed’s new trial, “External Evaluation of PAP...
12d ago
RMD
Amgen Tracks Long-Term Romosozumab Safety in Children: What Investors Should Know
Amgen Tracks Long-Term Romosozumab Safety in Children: What Investors Should Know
Amgen Inc ($AMGN) announced an update on their ongoing clinical study. This Amgen Inc. (AMGN) study, titled “Multicenter,...
12d ago
AMGN
AbbVie Completes Early ABBV-722 Tablet Study, Offering a Small Boost to Pipeline Visibility
AbbVie Completes Early ABBV-722 Tablet Study, Offering a Small Boost to Pipeline Visibility
Abbvie ($ABBV) announced an update on their ongoing clinical study. AbbVie (ABBV) has completed a Phase 1 study...
12d ago
ABBV
Novo Nordisk Tracks Real‑World Refixia® Use In Japan: What Investors Should Watch
Novo Nordisk Tracks Real‑World Refixia® Use In Japan: What Investors Should Watch
Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Novo Nordisk (NVO) is running a post‑marketing...
12d ago
NVO
Eli Lilly’s LY3537031 Renal Study Moves Forward, Shaping Early Pipeline Expectations
Eli Lilly’s LY3537031 Renal Study Moves Forward, Shaping Early Pipeline Expectations
Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. The Phase 1 study “A...
12d ago
LLY
Precision Bio’s 15-Year HBV Follow-Up Study: What Investors Should Know
Precision Bio’s 15-Year HBV Follow-Up Study: What Investors Should Know
Precision Biosciences ($DTIL) announced an update on their ongoing clinical study. The study “A Long-term Observational Study in...
14d ago
DTIL
Takeda Targets Older Adults With New Dengue Vaccine Study, Eyeing Long-Term Market Upside
Takeda Targets Older Adults With New Dengue Vaccine Study, Eyeing Long-Term Market Upside
Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda Pharmaceutical Co. (TAK) is running...
14d ago
TAK
ORKA-002 Psoriasis Trial Progress: What Oruka’s New Phase 2 Update Means for Investors
ORKA-002 Psoriasis Trial Progress: What Oruka’s New Phase 2 Update Means for Investors
Oruka Therapeutics, Inc. ($ORKA) announced an update on their ongoing clinical study. Oruka Therapeutics, Inc. is running a...
14d ago
ORKA
AstraZeneca Advances New Imaging Tool in Targeted Lung Cancer Trial
AstraZeneca Advances New Imaging Tool in Targeted Lung Cancer Trial
AstraZeneca plc ($GB:AZN) announced an update on their ongoing clinical study. AstraZeneca Launches Early Scan Study in Targeted...
14d ago
AZN
BioMarin’s BMN 333 Takes On Vosoritide in High Stakes Achondroplasia Trial
BioMarin’s BMN 333 Takes On Vosoritide in High Stakes Achondroplasia Trial
Biomarin Pharmaceutical Inc. ($BMRN) announced an update on their ongoing clinical study. BioMarin Pharmaceutical Inc. (BMRN) is running...
14d ago
BMRN
Takeda’s TAK-505 Trial Marks a New Bet on Difficult Solid Tumors
Takeda’s TAK-505 Trial Marks a New Bet on Difficult Solid Tumors
Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda has launched a first-in-human trial...
14d ago
TAK
Janux’s JANX011 First‑in‑Human Study: Early Safety Readout Could Shape Autoimmune Upside
Janux’s JANX011 First‑in‑Human Study: Early Safety Readout Could Shape Autoimmune Upside
Janux Therapeutics, Inc. ($JANX) announced an update on their ongoing clinical study. The Phase 1 study “A Phase...
14d ago
JANX
Pfizer Advances PF-08653944 Liver Study, Reinforcing Long-Term Pipeline Visibility
Pfizer Advances PF-08653944 Liver Study, Reinforcing Long-Term Pipeline Visibility
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has launched a Phase...
14d ago
PFE
Essilorluxottica Advances Next-Generation Myopia Control Lens Trial, With Potential Upside for ESLOY Investors
Essilorluxottica Advances Next-Generation Myopia Control Lens Trial, With Potential Upside for ESLOY Investors
Essilorluxottica (OTC) ($ESLOY) announced an update on their ongoing clinical study. Essilorluxottica’s latest clinical study, “Evaluation of the...
14d ago
ESLOY
Pfizer’s New Phase 1 Cancer Trial Adds Quiet Optionality to PFE’s Pipeline
Pfizer’s New Phase 1 Cancer Trial Adds Quiet Optionality to PFE’s Pipeline
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) has started a Phase...
14d ago
PFE
Pfizer Advances Early-Stage Obesity Asset With New Gastric Emptying Study
Pfizer Advances Early-Stage Obesity Asset With New Gastric Emptying Study
Pfizer Inc ($PFE) announced an update on their ongoing clinical study. Pfizer Inc. (PFE) is running a Phase...
14d ago
PFE